Zobrazeno 31 - 32
of 32
pro vyhledávání: '"Medina, Egmidio"'
Autor:
Abril-Rodríguez G; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA).; Department of Molecular and Medical Pharmacology, UCLA., Torrejon DY; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA)., Karin D; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA).; Department of Molecular and Medical Pharmacology, UCLA., Campbell KM; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA)., Medina E; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA)., Saco JD; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA)., Galvez M; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA)., Champhekar AS; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA)., Perez-Garcilazo I; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA)., Baselga-Carretero I; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA)., Singh J; Arcus Biosciences, Inc., Hayward, CA., Comin-Anduix B; Department of Surgery, Division of Surgical Oncology, UCLA.; Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095, USA., Puig-Saus C; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA).; Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94129, USA., Ribas A; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA).; Department of Molecular and Medical Pharmacology, UCLA.; Department of Surgery, Division of Surgical Oncology, UCLA.; Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94129, USA.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2022 Oct; Vol. 2 (10), pp. 1214-1228. Date of Electronic Publication: 2022 Oct 19.
Autor:
Abril-Rodriguez G; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA., Torrejon DY; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Liu W; Laboratory of Molecular Signaling, Division of Oral Biology and Medicine, School of Dentistry, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California, Los Angeles, Los Angeles, CA, USA., Zaretsky JM; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Nowicki TS; Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of California, Los Angeles, Los Angeles, USA., Tsoi J; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Puig-Saus C; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Baselga-Carretero I; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Medina E; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Quist MJ; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Garcia AJ; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Senapedis W; Karyopharm Therapeutics, Newton, MA, USA., Baloglu E; Karyopharm Therapeutics, Newton, MA, USA., Kalbasi A; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Surgery, Division of Surgical Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA., Cheung-Lau G; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Berent-Maoz B; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Comin-Anduix B; Department of Surgery, Division of Surgical Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA., Hu-Lieskovan S; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA., Wang CY; Laboratory of Molecular Signaling, Division of Oral Biology and Medicine, School of Dentistry, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California, Los Angeles, Los Angeles, CA, USA., Grasso CS; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Ribas A; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA. aribas@mednet.ucla.edu.; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA. aribas@mednet.ucla.edu.; Department of Surgery, Division of Surgical Oncology, University of California, Los Angeles, Los Angeles, CA, USA. aribas@mednet.ucla.edu.; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. aribas@mednet.ucla.edu.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. aribas@mednet.ucla.edu.
Publikováno v:
Nature cancer [Nat Cancer] 2020 Feb; Vol. 1 (2), pp. 264.
- [1]
- « Předchozí
- 1
- 2
- 3
- 4